None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Histologic diagnosis or clinically suspected of adenocarcinoma of the pancreas based on imaging tests or tumor markers ? Older than 20 years ? The performance status of patients based ECOG score less than 3 ? Patients with pancreatic cancer who were either surgically resectable or borderline resectable or can be resected after neoadjuvant chemotherapy because of advanced pancreatic cancer ? Patients who voluntarily decided to participate in this clinical study and signed the written informed consent
Exclusion criteria
Exclusion criteria: ? Previous history of irradiation in abdomen ? The treatment site could not be included in the appropriate radiation field, as judged by the radiation oncologist or the surgeon ? In case of distant metastasis ? A systemic condition that, under the judgment of the attending physician, would be difficult for surgery or radiation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Local recurrence rate | — |
Secondary
| Measure | Time frame |
|---|---|
| Acute, chronic toxicity;Disease free survival;Overall survival | — |
Countries
Korea, Republic of
Contacts
Yonsei University Health System, Gangnam Severance Hospital